Migraine is a recurring primary headache condition that affects the largest number of people among the many types of headaches, with 1 in 10 people suffering from migraine. Patients experience occasional head swelling and pain, mainly around the temples to the eyes. The attack is often preceded by aura of flashing lights, blurred vision, and numbness in the limbs, and gradually worsens with a throbbing pain. There are many triggers for migraine, such as insomnia, weakness, disease, stress, bad habits or emotions, which may trigger headaches in patients. Migraine is very harmful, and in addition to the damage that can be caused by the disease itself, it can lead to decreased ability to learn and work, reduced quality of life, and may even result in brain white matter lesions, cognitive decline, and posterior circulation asymptomatic cerebral infarction. Migraine is also often co-morbid with anxiety and depression. Modern clinical research confirms that migraine is a vascular neurological disease, which is mainly caused by adhesions and companion lines between nerves and blood vessels, as well as entanglement and entrapment. The reason why traditional medicine, acupuncture, massage and other treatments fail to cure migraine is that the root cause of the disease is not found. Microvascular decompression surgery is to target the “pain points” of the blood vessels and nerves that trigger migraine, and use minimally invasive technology to directly attack the lesion, find the closely connected nerves and blood vessels, and then isolate the responsible blood vessels under the microscope, so as to reduce the stimulation of the nerves by vascular expansion and achieve the purpose of treating migraine.